Home / Knowledge Centre /
Poster

Association of a DNA Damage Response Deficiency (DDRD) Assay with Prognosis in Resected Esophageal and Gastric Adenocarcinoma

Download the following Poster Presentation: Association of a DNA Damage Response Deficiency (DDRD) Assay with Prognosis in Resected Esophageal and Gastric Adenocarcinoma.

Conclusions:

The DDRD assay:
1. Is the first gene expression biomarker to utilise FFPE tissue in oesophago-gastric cancer.
2. Demonstrates a strong association with prognosis in:

  • EAC patients treated with neo-adjuvant chemotherapy
  • GC patients treated with surgery + adjuvant chemo/chemoXRT

3. Predicts Pathological Response to neo-adjuvant chemotherapy
4. Could personalise treatment approaches in oesophago-gastric cancer.

View Resource

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies